{"id":"W4417015358","doi":"10.1182/blood-2025-8236","title":"ALACRITY: A phase 1b/2 study of AZD0120 (BCMA/CD19 CAR-T cell therapy) in participants with relapsed or refractory light chain amyloidosis (AL)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"AL amyloidosis; Immunoglobulin light chain; Multiple myeloma; Population; Minimal residual disease; Amyloidosis; Bone marrow; Monoclonal; Refractory (planetary science); CD19","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002046465,0.001469602,0.001693104,0.0003149249,0.000564318,0.001337141,0.001132961,0.001770105,0.004757611],"category_scores_gemma":[0.0007574272,0.0006221825,0.001424349,0.0003010586,0.0009884551,0.0007402946,0.0004715113,0.00443379,0.001823615],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001290505,"about_ca_system_score_gemma":0.001778513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002042453,"about_ca_topic_score_gemma":0.005517638,"domain_scores_codex":[0.9994957,0.0002066637,0.00001662636,0.00009795785,0.0000507753,0.0001322076],"domain_scores_gemma":[0.9992399,0.00007658573,0.00007429104,0.00003882342,0.00007650514,0.0004938712],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6120121,0.1149196,0.01132455,0.001603673,0.002446723,0.0005423592,0.0007639418,0.00183958,0.08896958,0.0006375456,0.01536564,0.1495747],"study_design_scores_gemma":[0.5709918,0.3990974,0.01539847,0.00006689411,0.001066876,0.0004481814,0.0001464121,0.001286889,0.003666031,0.0004160315,0.007365408,0.0000495766],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9838918,0.004002742,0.000682516,0.001801549,0.0003267576,0.0031621,0.002977934,0.000257292,0.002897136],"genre_scores_gemma":[0.9784572,0.002605503,0.002512253,0.002815584,0.0002138615,0.004200957,0.003816756,0.0000621954,0.005315696],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004757611,"threshold_uncertainty_score":0.01591581,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04004829720196012,"score_gpt":0.3470153644016904,"score_spread":0.3069670671997303,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}